지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 538 - 545 (8page)
이용수
초록· 키워드
오류제보하기
Objective Depression is associated with a major disease burden, and many individuals suffer from depressive symptoms due to an insufficient response to ostensibly adequate antidepressant treatment. Therefore, it is important to identify reliable treatment response predictors for use in developing personalized treatment strategies. Methods The MAKE Biomarker discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) study was performed to identify predictors of antidepressant response using a 2-year naturalistic prospective design. Participants in the MAKE BETTER study were consecutively recruited from patients who visited the Psychiatry Department of Chonnam National University Hospital, Gwangju, South Korea for treatment of a depressive disorder. Data on demographic and clinical characteristics, genetic markers measured by whole-exome sequencing, and blood markers were obtained. The types and doses of antidepressants were determined based on the clinical judgment of the psychiatrist, and the treatment outcomes (e.g., depressive and other psychiatric symptoms and issues related to safety) were assessed. Results We will be able to use the data collected in this study to develop a treatment-response prediction index composed of biomarkers. Conclusion The MAKE BETTER study will provide an empirical basis for a personalized medicine approach to depression by enabling the prediction of antidepressant treatment response according the characteristics of each patient. It will thereby support evidencebased decision-making that decreases the use of a trial-and-error approach to the treatment of depressive disorders.
목차
등록된 정보가 없습니다.
참고문헌 (52)
참고문헌 신청
World Health Organization / 2008 / The Global Burden of Disease: 2004 Update / WHO Press
World Health Organization / Chapter 2: Burden of mental and behavioral disorders. In the World health report 2001-Mental health: New Understanding, New hope Impact of disorders
Al-Harbi KS / 2012 / Treatment-resistant depression: therapeutic trends, challenges, and future directions / Patient Prefer Adherence 6:369~388
Jenkins E / 2012 / Approaches to understanding and addressing treatment-resistant depression: a scoping review / Depress Res Treat 2012:469680
Trivedi MH / 2006 / Medication augmentation after the failure of SSRIs for depression / New Engl J Med 354:1243~1252
World Health Organization / Chapter 2: Burden of mental and behavioral disorders. In the World health report 2001-Mental health: New Understanding, New hope Impact of disorders
Al-Harbi KS / 2012 / Treatment-resistant depression: therapeutic trends, challenges, and future directions / Patient Prefer Adherence 6:369~388
Jenkins E / 2012 / Approaches to understanding and addressing treatment-resistant depression: a scoping review / Depress Res Treat 2012:469680
Trivedi MH / 2006 / Medication augmentation after the failure of SSRIs for depression / New Engl J Med 354:1243~1252
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response (MAKE BETTER) Study: Design and Methodology
PSYCHIATRY INVESTIGATION
2019 .01
-
우울증과 항우울작용에 관한 p11(S100A10)의 역할
생물정신의학
2016 .01
-
Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
2018 .01
-
항우울제 중단 증후군
신경정신의학
2024 .05
-
Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables
PSYCHIATRY INVESTIGATION
2020 .01
-
A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
Clinical Psychopharmacology and Neuroscience
2021 .01
-
새로운 우울증 치료 약물
생물정신의학
2016 .01
-
한국형 우울장애 약물치료 알고리듬 2017(III) : 유지치료
우울조울병
2017 .01
-
한국형 우울장애 약물치료 알고리듬 2017(II) : 정신병적 양상을 동반한 우울장애
우울조울병
2017 .01
-
한국형 우울장애 약물치료 알고리듬 2017(I) : 정신병적 양상이 없는 주요우울장애
우울조울병
2017 .01
-
Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment
PSYCHIATRY INVESTIGATION
2016 .01
-
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
PSYCHIATRY INVESTIGATION
2016 .01
-
일 대학병원 외래 우울증 환자의 항우울제 순응도와이에 미치는 요인
대한정신약물학회지
2015 .01
-
How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach
Clinical Psychopharmacology and Neuroscience
2020 .01
-
Is Advancing Circadian Rhythm the Mechanism of Antidepressants?
PSYCHIATRY INVESTIGATION
2019 .01
-
증상 중심의 항우울제 선택
대한의사협회지
2020 .01
-
Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
Clinical Psychopharmacology and Neuroscience
2020 .01
-
Associations of Serum Serotonin Levels with 12-week and 12-month Remission in Patients with Depressive Disorders
Clinical Psychopharmacology and Neuroscience
2022 .05
-
항우울제로 새롭게 등장한 ‘남용 물질’ - 약리학적 기전, 항우울 효과, 오남용 가능성에 대한 고찰
신경정신의학
2022 .11
-
우울증 환자에서 항우울제 단독요법과 항정신병제와 항우울제의 병용요법의 자살위험비교: 정신건강의학 공통 데이터 모델을 활용한 파일럿 연구
신경정신의학
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0